logo

For the Inventor, By the Inventor

Oberursel, Germany

Martin Scholz

This inventor holds 10 USPTO granted patents and 9 published patent applications and 11 EPO patents. Top assignee: Leukocare Ag. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Scholz. Retrieved from https://idiyas.com/inventor/martin-scholz-97vtkxof

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 70.0

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 53(Granted Patents)


Location History:

  • München, DE (2020)
  • Oberursel, DE (2016 - 2021)
  • Munich, DE (2021 - 2022)

Company Filing History:

goldMedal10 out of 13 
 
Leukocare Ag
 patents

Years Active: 2016-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 12350375 - Method for obtaining efficient viral vector-based compositions for vaccination or gene therapy (2025-07-08),
2. 11510871 - Method for producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation (2022-11-29),
3. 11166915 - Method for obtaining efficient viral vector-based compositions for vaccination or gene therapy (2021-11-09),
4. 11060068 - Stabilisation method for viruses or bacteria (2021-07-13),
5. 10588957 - Method for the production of stabile vaccines (2020-03-17),
6. 10421776 - Method for preventing the unfolding of a (poly)peptide and/or inducing the (re-)folding of a (poly)peptide (2019-09-24),
7. 10406271 - Method for filtering blood to produce plasma or serum (2019-09-10),
8. 9926383 - Biocompatible three dimensional matrix for the immobilization of biological substances (2018-03-27),
9. 9797895 - Stabilizing compositions for immobilized biomolecules (2017-10-24),
10. 9321848 - Method for preventing the unfolding of a (poly)peptide and/or inducing the (re-)folding of a (poly)peptide (2016-04-26),

Title: Martin Scholz: Innovator in Biopharmaceuticals

Introduction

Martin Scholz is a prominent inventor based in Oberursel, Germany. He has made significant contributions to the field of biopharmaceuticals, holding a total of 10 patents. His work focuses on developing innovative methods for producing viral vector-based compositions and biopharmaceutical drug products.

Latest Patents

One of his latest patents is a method for obtaining efficient viral vector-based compositions for vaccination or gene therapy. This invention involves preparing viral vector-based particles with a specific particle size distribution, utilizing replication-deficient viral vectors and a carefully formulated solution of sugars and excipients. Another notable patent is for producing low viscous and highly concentrated biopharmaceutical drug products. This method includes a two-phase process that ensures the biomolecule of interest is processed in the presence of amino acids and sugars, resulting in a highly concentrated product.

Career Highlights

Martin Scholz is currently associated with Leukocare AG, a company known for its innovative approaches in biopharmaceutical development. His expertise in the field has led to advancements that enhance the efficacy and stability of drug formulations.

Collaborations

He collaborates with talented professionals such as Kristina Kemter and Jens Altrichter, contributing to a dynamic research environment that fosters innovation.

Conclusion

Martin Scholz's work exemplifies the intersection of innovation and biopharmaceutical development. His patents reflect a commitment to advancing healthcare through scientific research and practical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…